Crossmark

Tyrosine kinase inhibitors combined with PD-1 inhibitors reduce peritoneal metastasis risk for patients with ruptured HCC receiving TACE/TAE: a multicenter retrospective study

Crossref DOI link: https://doi.org/10.1186/s12957-026-04322-6

Published Online: 2026-04-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ji, Jie

Zhang, Yaping

Yan, Lele

Sun, Xinjie

Wang, Jialei

Gu, Jie

Zhou, Weizhong

Lv, Penghua
License Information

Text and Data Mining valid from 2026-04-10

Version of Record valid from 2026-05-18
More Information

Article History

Received: 16 October 2025

Accepted: 30 March 2026

First Online: 10 April 2026

Declarations

:

: Study protocol followed the guidelines of the World Medical Association Declaration of Helsinki and were approved by the Ethics Committee of the Northern Jiangsu People’s Hospital, the First Affiliated Hospital of Nanjing Medical University, the First Affiliated Yancheng First People’s Hospital of Nanjing Medical University, and the First Affiliated Huaian First People’s Hospital of Nanjing Medical University. Under the condition of retrospective archival tissue collection, our study was exempted from the acquisition of informed consent from patients by the institutional review board.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below